Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Decaens

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
World Journal of Gastroenterology|October 3, 2022
Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolizationGael Roth, Yann Teyssier, Maxime Benhamou, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 18, 2016
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantationSamia Boussouar, Emmanuel Itti, Shih-Jui Lin, et al.
Journal of Cancer|August 18, 2021
GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal CancerSonia Brun, Jean-Marc Pascussi, Elena Patricia Gifu, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 1, 2013
Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis?Melanie Chiaradia, Laurence Baranes, Jeanne Tran Van Nhieu, et al.
Journal of Hepatology|January 30, 2017
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCCRiccardo Lencioni, Robert Montal, Ferran Torres, et al.
British Journal of Cancer|April 7, 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpressionThomas Decaens, Carlo Barone, Eric Assenat, et al.
Liver Cancer|August 11, 2022
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver CancersJames J Harding, Ahmad Awada, Gael Roth, et al.
Ebiomedicine|January 10, 2025
Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour modelCarole Fournier, Marion Mercey-Ressejac, Valentin Derangère, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 12, 2007
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control studySébastien Dharancy, Jeanne Boitard, Thomas Decaens, et al.
Open Forum Infectious Diseases|January 16, 2026
Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D)Patrick Ingiliz, Erwan Vo Quang, Gibril Ndow, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
World Journal of Gastroenterology|October 3, 2022
Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolizationGael Roth, Yann Teyssier, Maxime Benhamou, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 18, 2016
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantationSamia Boussouar, Emmanuel Itti, Shih-Jui Lin, et al.
Journal of Cancer|August 18, 2021
GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal CancerSonia Brun, Jean-Marc Pascussi, Elena Patricia Gifu, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 1, 2013
Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis?Melanie Chiaradia, Laurence Baranes, Jeanne Tran Van Nhieu, et al.
Journal of Hepatology|January 30, 2017
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCCRiccardo Lencioni, Robert Montal, Ferran Torres, et al.
British Journal of Cancer|April 7, 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpressionThomas Decaens, Carlo Barone, Eric Assenat, et al.
Liver Cancer|August 11, 2022
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver CancersJames J Harding, Ahmad Awada, Gael Roth, et al.
Ebiomedicine|January 10, 2025
Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour modelCarole Fournier, Marion Mercey-Ressejac, Valentin Derangère, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 12, 2007
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control studySébastien Dharancy, Jeanne Boitard, Thomas Decaens, et al.
Open Forum Infectious Diseases|January 16, 2026
Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D)Patrick Ingiliz, Erwan Vo Quang, Gibril Ndow, et al.
Pageof 13